Literature DB >> 17470798

Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity.

Huifang Ma1, Sylvain Lesné, Linda Kotilinek, Jill V Steidl-Nichols, Mathew Sherman, Linda Younkin, Steven Younkin, Colleen Forster, Nicolas Sergeant, André Delacourte, Robert Vassar, Martin Citron, Paulo Kofuji, Linda M Boland, Karen H Ashe.   

Abstract

The amyloid precursor protein (APP) undergoes sequential cleavages to generate various polypeptides, including the amyloid-beta protein (Abeta), which forms amyloid plaques in Alzheimer's disease (AD), secreted APPalpha (sAPPalpha) which enhances memory, and the APP intracellular domain (AICD), which has been implicated in the regulation of gene transcription and calcium signaling. The beta-site APP cleaving enzyme 1 (BACE1) cleaves APP in an activity-dependent manner to form Abeta, AICD, and secreted APPbeta. Because this neural activity was shown to diminish synaptic transmission in vitro [Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R (2003) Neuron 37:925-937], the prevailing notion has been that this pathway diminishes synaptic function. Here we investigated the role of this pathway in vivo. We studied transgenic mice overproducing APP that do not develop AD pathology or memory deficits but instead exhibit enhanced spatial memory. We showed enhanced synaptic plasticity in the hippocampus that depends on prior synaptic activity. We found that the enhanced memory and synaptic plasticity are abolished by the ablation of one or both copies of the BACE1 gene, leading to a significant decrease in AICD but not of any other APP cleavage products. In contrast to the previously described negative effect of BACE1-mediated cleavage of APP on synaptic function in vitro, our in vivo work indicates that BACE1-mediated cleavage of APP can facilitate learning, memory, and synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470798      PMCID: PMC1859992          DOI: 10.1073/pnas.0609521104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  BACE1 is the major beta-secretase for generation of Abeta peptides by neurons.

Authors:  H Cai; Y Wang; D McCarthy; H Wen; D R Borchelt; D L Price; P C Wong
Journal:  Nat Neurosci       Date:  2001-03       Impact factor: 24.884

2.  Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.

Authors:  Y Luo; B Bolon; S Kahn; B D Bennett; S Babu-Khan; P Denis; W Fan; H Kha; J Zhang; Y Gong; L Martin; J C Louis; Q Yan; W G Richards; M Citron; R Vassar
Journal:  Nat Neurosci       Date:  2001-03       Impact factor: 24.884

3.  A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60.

Authors:  X Cao; T C Südhof
Journal:  Science       Date:  2001-07-06       Impact factor: 47.728

4.  Extended analysis of path data from mutant mice using the public domain software Wintrack.

Authors:  D P Wolfer; R Madani; P Valenti; H P Lipp
Journal:  Physiol Behav       Date:  2001-08

5.  Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes.

Authors:  Sébastien S Hébert; Lutgarde Serneels; Alexandra Tolia; Katleen Craessaerts; Carmen Derks; Mikhail A Filippov; Ulrike Müller; Bart De Strooper
Journal:  EMBO Rep       Date:  2006-05-19       Impact factor: 8.807

6.  BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics.

Authors:  S L Roberds; J Anderson; G Basi; M J Bienkowski; D G Branstetter; K S Chen; S B Freedman; N L Frigon; D Games; K Hu; K Johnson-Wood; K E Kappenman; T T Kawabe; I Kola; R Kuehn; M Lee; W Liu; R Motter; N F Nichols; M Power; D W Robertson; D Schenk; M Schoor; G M Shopp; M E Shuck; S Sinha; K A Svensson; G Tatsuno; H Tintrup; J Wijsman; S Wright; L McConlogue
Journal:  Hum Mol Genet       Date:  2001-06-01       Impact factor: 6.150

7.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

Authors:  R Vassar; B D Bennett; S Babu-Khan; S Kahn; E A Mendiaz; P Denis; D B Teplow; S Ross; P Amarante; R Loeloff; Y Luo; S Fisher; J Fuller; S Edenson; J Lile; M A Jarosinski; A L Biere; E Curran; T Burgess; J C Louis; F Collins; J Treanor; G Rogers; M Citron
Journal:  Science       Date:  1999-10-22       Impact factor: 47.728

8.  APP processing and synaptic plasticity in presenilin-1 conditional knockout mice.

Authors:  H Yu; C A Saura; S Y Choi; L D Sun; X Yang; M Handler; T Kawarabayashi; L Younkin; B Fedeles; M A Wilson; S Younkin; E R Kandel; A Kirkwood; J Shen
Journal:  Neuron       Date:  2001-09-13       Impact factor: 17.173

9.  Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein.

Authors:  S M Fitzjohn; R A Morton; F Kuenzi; T W Rosahl; M Shearman; H Lewis; D Smith; D S Reynolds; C H Davies; G L Collingridge; G R Seabrook
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

10.  New protease inhibitors prevent gamma-secretase-mediated production of Abeta40/42 without affecting Notch cleavage.

Authors:  A Petit; F Bihel; C Alvès da Costa; O Pourquié; F Checler; J L Kraus
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

View more
  45 in total

1.  BACE1 gene promoter single-nucleotide polymorphisms in Alzheimer's disease.

Authors:  Weihui Zhou; Fang Cai; Yu Li; George S Yang; Kathleen D O'Connor; Robert A Holt; Weihong Song
Journal:  J Mol Neurosci       Date:  2010-05-09       Impact factor: 3.444

Review 2.  Synapses and Alzheimer's disease.

Authors:  Morgan Sheng; Bernardo L Sabatini; Thomas C Südhof
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-05-01       Impact factor: 10.005

Review 3.  Amyloid-β peptide: Dr. Jekyll or Mr. Hyde?

Authors:  Daniela Puzzo; Ottavio Arancio
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 4.  The effects of cholesterol on learning and memory.

Authors:  Bernard G Schreurs
Journal:  Neurosci Biobehav Rev       Date:  2010-05-12       Impact factor: 8.989

Review 5.  Non-coding RNA transcripts: sensors of neuronal stress, modulators of synaptic plasticity, and agents of change in the onset of Alzheimer's disease.

Authors:  Georges St Laurent; Mohammad Ali Faghihi; Claes Wahlestedt
Journal:  Neurosci Lett       Date:  2009-08-20       Impact factor: 3.046

Review 6.  Alzheimer's disease amyloid beta-protein and synaptic function.

Authors:  Tomas Ondrejcak; Igor Klyubin; Neng-Wei Hu; Andrew E Barry; William K Cullen; Michael J Rowan
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

Review 7.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

Review 8.  β-Secretase: its biology as a therapeutic target in diseases.

Authors:  Haibo Wang; Rena Li; Yong Shen
Journal:  Trends Pharmacol Sci       Date:  2013-02-27       Impact factor: 14.819

Review 9.  Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer's Disease.

Authors:  Wioletta Rozpedek; Lukasz Markiewicz; J Alan Diehl; Dariusz Pytel; Ireneusz Majsterek
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.